Myriad Genetics (MYGN) Tops Q3 EPS by 8c
Tweet
Share
E-mailGet Alerts MYGN Hot Sheet
Price: $5.62 -1.4%
EPS Growth %: -220.0%
Financial Fact:
Molecular diagnostic testing: 165.1M
Today's EPS Names:
ORPB, ONEG, NDLS, More
EPS Growth %: -220.0%
Financial Fact:
Molecular diagnostic testing: 165.1M
Today's EPS Names:
ORPB, ONEG, NDLS, More
Join SI Premium – FREE
Myriad Genetics (NASDAQ: MYGN) reported Q3 EPS of ($0.06), $0.08 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $173.1 million versus the consensus estimate of $156.2 million.
For earnings history and earnings-related data on Myriad Genetics (MYGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
- Canadian National Railway (CNI) Tops Q2 EPS by 15c
- Choiceone Financial Services, Inc. (COFS) Misses Q2 EPS by 5c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
